Patent · US Active

Plasma-derived nanoparticles

US12076417B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

Nanomedx, Inc.

Inventors

Miguel Angelo CORREIA DOS SANTOS · Sydney, AU
Elysse Filipe · Sydney, AU
Praveesuda LORWATTANAPONGSA · Sydney, AU
Marcela Bilek · Cloncurry, AU
Steven Garry Wise · Parramatta, AU

Key dates

Filing date	Dec 15, 2022
Grant date	Sep 3, 2024
Priority date	—
Expiry date	Dec 15, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC23C16/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to nanoparticles, including nanoparticles derived from a plasma, and their use in the formation of conjugates. The nanoparticles can be stably conjugated to a wide variety of second species, forming conjugates which can be used, for example, in therapeutic, diagnostic and experimental methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.